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           SUMMARY   
DNA INVESTIGATION IN THE EBC IN NON-SMALL CELL LUNG CANCER 
   
       Long-term exposure to carcinogens may lead to changes in the genes which 
control cell proliferation by the way of impairment in the genetic structure. When mutations 
develop on the oncogenic and/or tumor suppressor genes, it would be an initial step in the 
tumor development.        
       EBC, one of the materials which is used to detect mutations in the early period, is 
collected by completely non-invasive a technique which has no risk for the patient. There are 
limited study which investigated the genetic examinations in the EBC. We aimed to 
investigate whether EBC samples are suitable for the detection of DNA or not in NSCLC and 
control patients.     
       26 NSCLC patients and 20 male patients who had no lung cancer were included in 
the study. EBC procedure was performed by the help of  Eco Screen- Jaeger device in 10-15 
minutes during breathing at the tidal volume. DNA was isolated invitek tissue spin-column 
DNA isolation kit in the collected EBC.          
         DNA amount was two fold high in the NSCLC group than non-cancer patients in 
spite of short time (p>0,05). However, in cancer group, when comparing the groups which 
had endobronchial lesion or hadn’t, DNA amount was found lower in patients who had 
endobronchial lesions than hadn’t (p>0.05). Although, there was no relationship between 
DNA amount and EBC collection time, collected sample amount and volume of expiration air 
volume in the cancer group, there was a positive relationship between DNA amount and EBC 
collection time in the non-cancer group.    
      This may be explained by the pathological changes which occur at the cellular 
level in the lungs during cancer development process. However, it may also result from 
relative decrease which develops from redundancy of EBC volume in the non-cancer group. It 
may be considered that DNA source in EBC is the pathological changes of the systemic 
inflammatory response other than localized lesion in the lungs. Since detectable level of DNA 
is found to be in EBC samples, EBC may be considered as a non-invasive method in 
screening the risk groups and/or the follow-up prognosis in diagnosed patients.   
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